Home  /  Resource Library  /  Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation

Results of a study showing bendamustine had favourable results when used in combination therapy for relapsed Hodgkin’s